NSE shareholding pattern
AstraZeneca Pharma India Limited shareholding pattern
As of the Sep 2026 shareholding pattern (quarter ended 2026-09-30), promoters held 75%, FIIs 2.64%, and DIIs 7.09% of AstraZeneca Pharma India Limited (ASTRAZEN). Against the Jun 2026 pattern, FII holding is down 0.04 percentage points (2.68% → 2.64%), DII up 1.01 points (6.08% → 7.09%), and promoter holding unchanged at 75%. The table below shows how promoter, FII, DII and public holding has moved quarter by quarter, taken from the NSE shareholding pattern.
Smart Money Report, Q2 FY27: shareholding patterns for the quarter ended 30 Sep 2026
Definition
A shareholding pattern is the quarterly breakdown of who owns a listed company, split across promoters, foreign institutional investors (FII), domestic institutional investors (DII), and the public. Indian companies file it every quarter under SEBI listing rules. Source: NSE shareholding pattern.
AstraZeneca Pharma India Limited shareholding by quarter
| Quarter | Promoter % | FII % | DII % | Public % | Filed |
|---|---|---|---|---|---|
| Sep 2026 | 75 | 2.64 | 7.09 | 15.27 | 2026-09-30 |
| Jun 2026 | 75 | 2.68 | 6.08 | 16.24 | 2026-06-30 |
| Mar 2026 | 75 | 2.78 | 5.79 | 16.43 | 2026-03-31 |
| Dec 2025 | 75 | 2.71 | 5.55 | 16.74 | 2025-12-31 |
| Sep 2025 | 75 | 2.74 | 5.26 | 17 | 2025-09-30 |
| Jun 2025 | 75 | 3.03 | 4.55 | 17.42 | 2025-06-30 |
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Related on Flock
- Smart money moves this filing week (insider trades, bulk deals and stake disclosures from the last 7 days)
- All NSE shareholding patterns (browse every company by name)
- What is a 13F filing? (how the US equivalent disclosure works)
- FII and DII activity, sourced and dated
- Today's NSE and BSE bulk and block deals
- Shareholding patterns for other companies in the same industry: Aurobindo Pharma Limited, Bajaj Healthcare Limited, Biocon Limited, Blue Jet Healthcare Ltd, Caplin Point Laboratories Ltd, Cipla Limited, Cohance Lifesciences Limited, Concord Biotech Limited
- When smart money's filings overlap (multi-entity disclosure overlap, explained)
Frequently asked questions
What is the promoter holding in AstraZeneca Pharma India Limited?
As of the Sep 2026 shareholding pattern, promoters held 75% of AstraZeneca Pharma India Limited (ASTRAZEN). Figures are taken from the NSE shareholding pattern filing dated 2026-09-30 and may change each quarter. Not investment advice.
What is the FII holding in AstraZeneca Pharma India Limited?
Foreign institutional investors held 2.64% of AstraZeneca Pharma India Limited as of the Sep 2026 pattern, versus 2.68% in the Jun 2026 pattern. Source: NSE shareholding pattern, quarter ended 2026-09-30. Not investment advice.
How much did FII holding in AstraZeneca Pharma India Limited change in the Sep 2026 quarter?
FII holding in AstraZeneca Pharma India Limited was 2.68% in the Jun 2026 pattern and 2.64% in Sep 2026, a difference of 0.04 percentage points down. Promoter holding was unchanged at 75% across the two filings, and both figures are percentages as filed. Source: NSE shareholding pattern, quarter ended 2026-09-30. Not investment advice.
How often is the shareholding pattern updated?
Listed Indian companies disclose their shareholding pattern every quarter under SEBI's listing rules. Flock re-stamps each page when a new quarterly pattern is filed, so the freshness chip reflects the true age of the latest data.
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.